HomeAPGE • NASDAQ
add
Apogee Therapeutics Inc
Previous close
$49.21
Day range
$39.07 - $48.34
Year range
$30.88 - $72.29
Market cap
2.40B USD
Avg Volume
510.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 58.69M | 141.46% |
Net income | -49.02M | -135.21% |
Net profit margin | — | — |
Earnings per share | -0.86 | -68.63% |
EBITDA | -58.64M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 526.05M | 24.40% |
Total assets | 776.29M | 82.05% |
Total liabilities | 41.88M | 143.82% |
Total equity | 734.40M | — |
Shares outstanding | 56.90M | — |
Price to book | 3.81 | — |
Return on assets | -18.61% | — |
Return on capital | -19.25% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -49.02M | -135.21% |
Cash from operations | -42.52M | -113.90% |
Cash from investing | -146.38M | 37.50% |
Cash from financing | 383.00K | -99.88% |
Net change in cash | -188.52M | -398.29% |
Free cash flow | -27.54M | -127.78% |
About
Founded
2022
Headquarters
Website
Employees
91
